Table 3.
Changes induced by the applied procedure in the NW group—training and supplementation, in SP by supplementation and values of control group (CG).
| Nordic Walking (n = 33) |
Control Group (n = 34) |
Supplemented Group (n = 27) |
rANOVA | |||||
|---|---|---|---|---|---|---|---|---|
| Baseline | After 12w | Baseline | After 12w | Baseline | After 12w | Interaction | ηp2 | |
| Homocysteine (µmol·L−1) | 9.91 (2.78) | 8.90 * (3.14) | 8.93 (2.35) | 9.51 (3.42) | 9.85 (3.20) | 9.35 (2.69) | p = 0.03 | 0.08 |
| Ferritin (ng·mL−1) | 94.23 (62.49) | 73.15* (47.04) | 127.94 (84.94) | 117.05 (87.51) | 137.85 (81.88) | 124.68 (72.11) | p = 0.29 | 0.03 |
| Glucose (mg·dL−1) | 96.64 (12.25) | 95.06 (12.05) | 101.88 (12.33) | 98.29 (10.47) | 99.69 (13.62) | 98.54 (13.64) | p = 0.33 | 0.01 |
| Vitamin D (ng·mL−1) | 23.01 (9.97) | 59.48* (27.61) | 24.64 (11.61) | 22.11 (9.52) | 27.37 (8.14) | 63.29 * (14.25) | p = 0.00 | 0.51 |
| BDNF (ng·mL−1) | 42.74 (19.92) | 31.93 * (15.91) | 33.52 (12.61) | 28.96 (12.86) | 37.75 (8.08) | 16.94 * (12.78) | p = 0.01 | 0.11 |
| Irisin (ng·mL−1) | 12.00 (4.44) | 12.45 (6.31) | 11.66 (4.06) | 11.89 (3.71) | 12.17 (7.62) | 11.30 (6.51) | p = 0.49 | 0.02 |
| IL-6 (pg·mL−1) | 1.32 (0.68) | 1.59 (0.78) | 1.89 (0.98) | 1.86 (1.56) | 2.66 (1.38) | 3.11 (1.92) | p = 0.56 | 0.01 |
| hsCRP (mg·L−1) | 2.60 (2.21) | 2.82 (3.04) | 3.73 (3.31) | 2.75 (3.18) | 2.01 (1.92) | 2.15 (1.97) | p = 0.08 | 0.06 |
Values are means (SD). Interaction—Group x time interaction, partial eta squared (ηp2) values are provided to estimate the effect sizes of the repeated measurment analyses of variance (rANOVAs). *—Significant differences after 12 weeks, p < 0.05, 12w—12 weeks.